Cortavance 0.584 mg Solution is a Health Canada–registered veterinary drug (DIN 02376482) held by Virbac Ah, Inc., containing Hydrocortisone Aceponate. Health Canada lists its status as Marketed (status date 19 Jun 2012). Nexara Health has matched 12 registrations of Hydrocortisone Aceponate across 5 other regulated markets.
Health Canada registration
| DIN | 02376482 |
|---|---|
| Brand name | Cortavance |
| Active ingredient | Hydrocortisone Aceponate |
| Strength | 0.584 mg |
| Dosage form | Solution |
| Route | Topical |
| Company | Virbac Ah, Inc. |
| Status | Marketed — 19 Jun 2012 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Hydrocortisone Aceponate registered in other markets
12 registrations of the same molecule in 5 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| European Union (EMA) | Alcort | — | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Cortaderm | — | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Cortavance | — | Authorised | EMA centrally authorised | ||
| European Union (EMA) | Hydrocortisone aceponate Ecuphar (previously Cortacare) | — | Authorised | EMA centrally authorised | ||
| Hong Kong | Efficort Hydrophile Cream 0.127% | Laboratoires Bailleul Limited | Registered | DH Drug Office | ||
| Hong Kong | Efficort Lipocream 0.127% | Laboratoires Bailleul Limited | Registered | DH Drug Office | ||
| Poland | Alcort | Nextmune Italy S.r.l. | 0,584 mg/ml | Roztwór do natryskiwania na skórę | Bezterminowe | URPL RPL |
| Poland | Cortaderm | Alfasan Nederland BV | 0,584 mg/ml | Aerozol na skórę, roztwór | URPL RPL | |
| Singapore | Efficort Cream 0.127% | Aenon Pharmaceuticals Sea Pte. Ltd. | 0.13% | Cream | Prescription Only | HSA |
| Singapore | Efficort Lipocream 0.127% | Aenon Pharmaceuticals Sea Pte. Ltd. | 0.13% | Cream | Prescription Only | HSA |
| United States | Hydrocortisone Aceponate | Curia Spain S.A.U. | Powder | FDA NDC | ||
| United States | Hydrocortisone Aceponate | Hovione Farmaciencia SA | Powder | FDA NDC |
See every manufacturer of Hydrocortisone Aceponate worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Cortavance (DIN 02376482) marketed in Canada?
Yes. Health Canada lists DIN 02376482 as Marketed as of 19 Jun 2012.
Who holds the Canadian licence for this product?
Virbac Ah, Inc. is the company of record in the Health Canada Drug Product Database.
Is Hydrocortisone Aceponate registered outside Canada?
Yes — Nexara Health has matched 12 registrations in 5 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02376482, status date 2012-06-19; national medicine registries: DH Drug Office, EMA centrally authorised, FDA NDC, HSA, URPL RPL. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02376482, status date 2012-06-19; national medicine registries: DH Drug Office, EMA centrally authorised, FDA NDC, HSA, URPL RPL.
Health Canada Drug Product Database (DPD), DIN 02376482, status date 2012-06-19; national medicine registries: DH Drug Office, EMA centrally authorised, FDA NDC, HSA, URPL RPL. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.